Professor of Diabetes and Clinical Research at the Centre for Diabetes at Barts and The London School of Medicine & Dentistry, London, and Professor of Endocrinology & Metabolic Diseases at the University Campus Bio-Medico in Rome. ITALY
Paolo Pozzilli has received his Degree in Medicine and specialized in Endocrinology & Metabolic Diseases from University “Sapienza” of Rome, Italy. Since then he has worked mainly in the field of diabetes with particular focus into type 1 diabetes (T1D) pathogenesis and prevention in collaboration with several investigators around the world for more than 30 years. He is an internationally recognized leader in this field including studies on the etiology, pathogenesis and novel forms of therapeutic intervention (immunotherapy) of T1D. He was able to establish the first joint PhD programme in diabetes including four Universities (Barts and The London, UK; University of Ulm, Germany; University of Barcelona, Spain and University Campus Bio-Medico, Rome, Italy. He has served as consultant on T1D to countries including Middle East (UAE, Egypt), Europe (Belgium, Finland, Spain, Poland, Sweden) and has been on the scientific review committee of JDRF (USA) in different periods for a total of nearly 10 years. He has also served for the EU in the grant selection for the 5th Framework Programme and is currently the Editor of Diabetes Metabolism Research & Reviews. Professor Pozzilli has received several awards , the most significant ones include the Andrew Cudworth Memorial Award by the British Diabetic Association, the Morgagni Award for Best Young Investigators, the Celso Prize by the Italian Society of Diabetology, the Marie Kugel Award by the Juvenile Diabetes Foundation (USA), the Diabetes Honoris Causa by the Paulescu Foundation, Romanian Diabetes Society. He has published a total of 425 peer reviewed articles (Pubmed).